@sigtrans-sttt.bsky.social#AcneVulgaris presents significant clinical challenges and psychological comorbidities that demand precision therapeutic strategies.
This review explores molecular mechanisms, emerging biologics, and novel #Vaccines.
#STTT #OpenAccess: doi.org/10.1038/s413...
#CellSignaling #TherapeuticTargets
@sigtrans-sttt.bsky.social#ChronicPain is a major global health challenge requiring precise molecular insights & innovative therapeutics. This work reviews neural circuit mechanisms, current therapeutic interventions, and emerging #Neuromodulation strategies.
@csisingapore.bsky.socialEarlier this month, CSI Singapore hosted Dr. Minkyu Kim from University of Texas Health San Antonio. He spoke on the topic “Studying Cancer Biology with Quantitative Functional Proteomics: Mapping the SPN-PP1 Axis”.
#proteomics #functionalproteomics #molecularbiology #cellsignaling #cancerresearch
@iamashish008.bsky.socialExcited to share my first paper as a co-first author, now published in the Journal of Clinical Investigation! 🎉
📄 J Clin Invest. 2026
🔗 doi.org/10.1172/JCI2...
#Diabetes #BetaCells #CellSignaling #BiomedicalResearch #JCI #PhDResearchhttps://www.jci.org/articles/view/202344
@jcb.orgSpatially ordered zygotic genome activation fulfills embryo quality control. New study from Wenchao Qian, Hui Chen, Hongju Lee, and Matthew C. Good @buenoscience.bsky.social @upenn.edu:
rupress.org/jcb/article/...
#Technology #Development #CellCycle #CellDdivision #CellSignaling
@pierre-maisonneuve.bsky.social🧬 Announcing the French Kinase Conference - 1st edition! Nov 9–10, 2026, @iecb.bsky.social
We aim to bring together the French community of biologists, structural biologists, and medicinal chemists working on protein kinases.